MoonLake Immunotherapeutics Analysis
| Analyst Ratings |
|
Average Target Price
|
63.27
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
11
|
|
# Buys
|
2
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.44
|
-0.56
|
-0.12
|
-27.27%
|
|
2024-06-30
|
-0.28
|
-0.39
|
-0.11
|
-39.29%
|
|
2024-03-31
|
-0.19
|
-0.22
|
-0.03
|
-15.79%
|
|
2023-12-31
|
-0.23
|
-0.12
|
0.11
|
47.83%
|
|
2023-09-30
|
-0.23
|
-0.18
|
0.05
|
21.74%
|
|
2023-06-30
|
-0.27
|
-0.23
|
0.04
|
14.81%
|
|
2023-03-31
|
-0.31
|
-0.23
|
0.08
|
25.81%
|
|
2022-12-31
|
-0.33
|
-0.31
|
0.02
|
6.06%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-1.17
|
|
2023-12-31
|
-0.76
|
|
2022-12-31
|
-1.27
|
|
2021-12-31
|
-0.31
|
|
2020-12-31
|
-0.01
|